<p><strong>Quoin Pharmaceuticals Ltd – ADR</strong> (NASDAQ:QNRX) 的股票在周五早晨交易中上涨，此前该公司宣布进行最高达 1.045 亿美元的私募融资。与新老机构投资者达成的交易包括初始的 1680 万美元的前期资金。</p>
<p><strong>需要了解的事项：</strong> 这家专注于罕见病和孤儿病的临床阶段专业制药公司，将发行美国存托股票和预先融资的认股权证的组合。融资还包括四系列的认股权证，如果行使，将使总收益达到 1.045 亿美元。</p>
<p>该公司计划将净收益用于一般企业用途，包括营运资金、研发以及完成其针对奈瑟顿综合症的 QRX003 药物的临床开发。私募预计将在 10 月 14 日左右完成。</p>
<p>虽然此类发行有时会对股票造成压力，但股票可能上涨的原因是该交易的定价高于公司前一天的收盘价 8.16 美元。</p>
<p><strong>Benzinga Edge 排名：</strong> 根据 Benzinga Edge 的股票排名，QNRX 目前的动量得分为 21.05，得益于短期和中期价格趋势的积极表现。</p>
<p><strong>QNRX 价格走势：</strong> 根据 Benzinga Pro 的数据，Quoin Pharmaceuticals 的股票在周五发布时上涨了 149.14%，报 20.40 美元。</p>
<p><strong>另请阅读：阿斯利康在弗吉尼亚州的投资扩大至 45 亿美元，用于癌症和肥胖药物</strong></p>
<h2>如何购买 QNRX 股票</h2>
<p>除了前往经纪平台购买股票或部分股票外，您还可以通过购买持有该股票的交易所交易基金（ETF）或在 401(k) 中分配策略以获取共同基金或其他工具的股票。</p>
<p>例如，在 Quoin Pharmaceuticals 的案例中，它属于医疗保健行业。ETF 可能会持有许多流动性强且规模大的公司股票，从而帮助跟踪该行业，使投资者能够接触到该细分市场的趋势。</p>
<p><em>图片来源：Shutterstock</em></p>

QNRX

74907L409

<p>Quoin Pharmaceuticals（纳斯达克代码：QNRX）股价上涨 149.14%，至 20.40 美元，此次上涨是由于宣布了一项最高可达 1.045 亿美元的私募融资。该交易包括初始融资 1680 万美元，并将涉及发行美国存托股票和预先融资的认股权证。融资所得将用于一般企业用途，包括 QRX003 药物的研发。预计融资将在 10 月 14 日左右完成，发行价格高于之前的收盘价 8.16 美元</p>

<p><strong>Quoin Pharmaceuticals Ltd – ADR</strong> (NASDAQ:QNRX) shares are trading higher Friday morning after the company announced a private placement financing of up to $104.5 million. The deal with new and existing institutional investors includes an initial upfront funding of $16.8 million.</p>
<div class="lb-trans"><p><strong>Quoin Pharmaceuticals Ltd – ADR</strong> (NASDAQ:QNRX) 的股票在周五早晨交易中上涨，此前该公司宣布进行最高达 1.045 亿美元的私募融资。与新老机构投资者达成的交易包括初始的 1680 万美元的前期资金。</p>
</div><p><strong>What To Know:</strong> The clinical-stage specialty pharmaceutical company, which focuses on rare and orphan diseases, will issue a combination of American Depositary Shares and pre-funded warrants. The financing also includes four series of warrants, which, if exercised, would bring the total proceeds to the $104.5 million mark.</p>
<div class="lb-trans"><p><strong>需要了解的事项：</strong> 这家专注于罕见病和孤儿病的临床阶段专业制药公司，将发行美国存托股票和预先融资的认股权证的组合。融资还包括四系列的认股权证，如果行使，将使总收益达到 1.045 亿美元。</p>
</div><p>The company plans to use the net proceeds for general corporate purposes, including working capital, research and development, and the completion of clinical development for its QRX003 drug for Netherton Syndrome. The private placement is expected to close on or about October 14.</p>
<div class="lb-trans"><p>该公司计划将净收益用于一般企业用途，包括营运资金、研发以及完成其针对奈瑟顿综合症的 QRX003 药物的临床开发。私募预计将在 10 月 14 日左右完成。</p>
</div><p>While such offerings can sometimes pressure a stock, shares are likely trading higher because the deal was priced at a premium to the company’s prior day’s closing price $8.16.</p>
<div class="lb-trans"><p>虽然此类发行有时会对股票造成压力，但股票可能上涨的原因是该交易的定价高于公司前一天的收盘价 8.16 美元。</p>
</div><p><strong>Benzinga Edge Rankings:</strong> According to Benzinga Edge stock rankings, QNRX currently has a Momentum score of 21.05, supported by positive short and medium-term price trends.</p>
<div class="lb-trans"><p><strong>Benzinga Edge 排名：</strong> 根据 Benzinga Edge 的股票排名，QNRX 目前的动量得分为 21.05，得益于短期和中期价格趋势的积极表现。</p>
</div><p><strong>QNRX Price Action:</strong> Quoin Pharmaceuticals shares were up 149.14% at $20.40 at the time of publication Friday, according to Benzinga Pro.</p>
<div class="lb-trans"><p><strong>QNRX 价格走势：</strong> 根据 Benzinga Pro 的数据，Quoin Pharmaceuticals 的股票在周五发布时上涨了 149.14%，报 20.40 美元。</p>
</div><p><strong>Read Also: AstraZeneca Expands Virginia Investment To $4.5 Billion For Cancer, Obesity Drugs</strong></p>
<div class="lb-trans"><p><strong>另请阅读：阿斯利康在弗吉尼亚州的投资扩大至 45 亿美元，用于癌症和肥胖药物</strong></p>
</div><h2>How To Buy QNRX Stock</h2>
<div class="lb-trans"><h2>如何购买 QNRX 股票</h2>
</div><p>Besides going to a brokerage platform to purchase a share – or fractional share – of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument.</p>
<div class="lb-trans"><p>除了前往经纪平台购买股票或部分股票外，您还可以通过购买持有该股票的交易所交易基金（ETF）或在 401(k) 中分配策略以获取共同基金或其他工具的股票。</p>
</div><p>For example, in Quoin Pharmaceuticals’ case, it is in the Health Care sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.</p>
<div class="lb-trans"><p>例如，在 Quoin Pharmaceuticals 的案例中，它属于医疗保健行业。ETF 可能会持有许多流动性强且规模大的公司股票，从而帮助跟踪该行业，使投资者能够接触到该细分市场的趋势。</p>
</div><p><em>Image: Shutterstock</em></p>
<div class="lb-trans"><p><em>图片来源：Shutterstock</em></p>
</div>

Quoin Pharmaceuticals (QNRX) 股票在周五大幅上涨：究竟发生了什么？